2025
SJR Q1
JCR Q3 · 2
30 eşleşen makale
SCIE
Dergi ayrıntısı
Cardiovascular Pathology
- Yayıncı
- Elsevier Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1054880718791336
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,774
- Quartile Q1
- H-Index 86
- Atıf/yayın 2,23
- Doküman (3y) 174
- Atıf (3y) 356
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 2,1
- JCI 0,67
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cardiology and Cardiovascular Medicine Q2
- Medicine (miscellaneous) Q2
- Pathology and Forensic Medicine Q1
Alanlar
- Medicine
WoS kategorileri
- Cardiac & Cardiovascular System | Pathology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q3 | 0,774 | 2 | 2,1 | 0,67 | Q2 | 86 |
| 2024 | Q2 | Q3 | 0,584 | 1,9 | 2,1 | 0,79 | Q2 | 83 |
| 2023 | Q2 | Q2 | 0,68 | 2,3 | 2 | 0,9 | Q2 | 83 |
| 2022 | Q1 | Q2 | 0,908 | 3,7 | 2,6 | 1 | Q1 | 83 |
| 2021 | Q1 | Q2 | 0,804 | 4 | 3,1 | 0,81 | Q2 | 83 |
| 2020 | Q2 | Q3 | 0,544 | 2,2 | 2,5 | 0,59 | Q2 | 83 |
| 2019 | Q2 | Q3 | 0,681 | 1,8 | 2,3 | 0,67 | Q2 | 83 |
| 2018 | — | Q3 | — | 1,8 | 2,2 | 0,7 | Q2 | — |
| 2017 | Q2 | Q2 | 0,885 | 2,5 | 2,3 | 0,76 | Q2 | 83 |
| 2016 | Q1 | Q2 | 1,101 | 2,4 | 2,5 | — | — | 83 |
| 2015 | Q1 | Q2 | 0,981 | 2,2 | 2,2 | — | — | 83 |
| 2014 | Q1 | Q2 | 0,956 | 2 | 2,1 | — | — | 83 |
| 2013 | Q2 | Q2 | 0,778 | 2,3 | 2,1 | — | — | 83 |
| 2012 | Q2 | Q2 | 0,638 | 2,4 | 2 | — | — | 83 |
| 2011 | Q2 | Q2 | 0,662 | 2,1 | 1,9 | — | — | 83 |
| 2010 | Q2 | Q3 | 0,641 | 1,9 | 2 | — | — | 83 |
| 2009 | — | Q3 | — | 1,6 | 1,8 | — | — | — |
| 2008 | — | Q2 | — | 2 | 2 | — | — | — |
| 2007 | — | Q2 | — | 1,8 | 2 | — | — | — |
| 2006 | — | Q2 | — | 1,9 | — | — | — | — |
| 2005 | — | Q2 | — | 1,7 | — | — | — | — |
| 2004 | — | Q3 | — | 1,5 | — | — | — | — |
| 2003 | — | Q2 | — | 2 | — | — | — | — |
| 2002 | — | Q2 | — | 1,3 | — | — | — | — |
| 2001 | — | Q3 | — | 0,8 | — | — | — | — |
| 2000 | — | Q4 | — | 0,3 | — | — | — | — |
| 1999 | — | Q3 | — | 0,9 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
| 1997 | — | Q2 | — | 0,8 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 143/237 |
| 2025 | PATHOLOGY | SCIE | Q3 | Q3 | 50/89 |
| 2024 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 131/231 |
| 2024 | PATHOLOGY | SCIE | Q3 | Q2 | 49/90 |
| 2023 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 104/222 |
| 2023 | PATHOLOGY | SCIE | Q2 | Q2 | 42/88 |
| 2022 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q1 | 58/143 |
| 2022 | PATHOLOGY | SCIE | Q2 | Q2 | 23/76 |
| 2021 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 62/143 |
| 2021 | PATHOLOGY | SCIE | Q2 | Q2 | 28/77 |
| 2020 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 99/142 |
| 2020 | PATHOLOGY | SCIE | Q3 | Q3 | 48/77 |
| 2019 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 96/138 |
| 2019 | PATHOLOGY | SCIE | Q3 | Q3 | 51/78 |
| 2018 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | Q2 | 94/136 |
| 2018 | PATHOLOGY | SCIE | Q3 | Q2 | 48/76 |
| 2017 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | Q2 | 61/128 |
| 2017 | PATHOLOGY | SCIE | Q2 | Q2 | 30/79 |
| 2016 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 62/126 |
| 2016 | PATHOLOGY | SCIE | Q2 | — | 30/79 |
| 2015 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 62/124 |
| 2015 | PATHOLOGY | SCIE | Q2 | — | 29/79 |
| 2014 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 66/123 |
| 2014 | PATHOLOGY | SCIE | Q2 | — | 37/76 |
| 2013 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 59/125 |
| 2013 | PATHOLOGY | SCIE | Q2 | — | 29/76 |
| 2012 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 59/124 |
| 2012 | PATHOLOGY | SCIE | Q2 | — | 29/77 |
| 2011 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 60/117 |
| 2011 | PATHOLOGY | SCIE | Q2 | — | 34/79 |
| 2010 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 61/114 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 39/76 |
| 2009 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 54/95 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 41/71 |
| 2008 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 42/79 |
| 2008 | PATHOLOGY | SCIE | Q2 | — | 33/69 |
| 2007 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 38/75 |
| 2007 | PATHOLOGY | SCIE | Q2 | — | 32/66 |
| 2006 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 32/74 |
| 2006 | PATHOLOGY | SCIE | Q2 | — | 29/64 |
| 2005 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 33/72 |
| 2005 | PATHOLOGY | SCIE | Q2 | — | 32/66 |
| 2004 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 36/71 |
| 2004 | PATHOLOGY | SCIE | Q3 | — | 34/65 |
| 2003 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 26/70 |
| 2003 | PATHOLOGY | SCIE | Q2 | — | 24/64 |
| 2002 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 33/66 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 34/64 |
| 2001 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 46/65 |
| 2001 | PATHOLOGY | SCIE | Q3 | — | 44/66 |
| 2000 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q4 | — | 59/63 |
| 2000 | PATHOLOGY | SCIE | Q4 | — | 63/67 |
| 1999 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 35/67 |
| 1999 | PATHOLOGY | SCIE | Q3 | — | 45/66 |
| 1998 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q3 | — | 36/62 |
| 1998 | PATHOLOGY | SCIE | Q3 | — | 48/68 |
| 1997 | CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | — | 30/62 |
| 1997 | PATHOLOGY | SCIE | Q3 | — | 44/66 |